4,4,5,5-Tetramethyl-2-propyl-1,3,2-dioxaborolane

Catalog No. :
ACTPSA726
CAS No. :
67562-19-0
Molecular Formula :
C9H19BO2
Molecular Weight :
170.06

IUPAC Name:4,4,5,5-tetramethyl-2-propyl-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-propyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$111.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4,5,5-Tetramethyl-2-propyl-1,3,2-dioxaborolane
IUPAC Name4,4,5,5-tetramethyl-2-propyl-1,3,2-dioxaborolane
MDL No.MFCD12546187
Molecular FormulaC9H19BO2
Molecular Weight170.06
SMILESCCCB1OC(C)(C)C(C)(C)O1
InChI KeyBTSWCGATJFXUHR-UHFFFAOYSA-N
Synonym67562-19-0 | 1-Propylboronic acid pinacol ester | 4,4,5,5-tetramethyl-2-propyl-1,3,2-dioxaborolane | MFCD12546187 | 1-Propylboronicacidpinacolester,98% | n-Propylboronicacidpinacol | 4,4,5,5-Tetramethyl-2-n-propyl-1,3,2-dioxaborolane | Propylboronic Acid Pinacol Ester |
CAS No.67562-19-0
PubChem CID10103569

Safety Data

Pictogram
Flammable
Signal Word
Gefahr
Hazard Statement(s)
H225
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P370+P378-P403+P235-P501

Synthetic Route by SureRoute

1. ACTPSA726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTPSA726 route product structure diagram
    ACTPSA72667562-19-0 In Stock
Inquiry

2. ACTPSA726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. ACYCJI648 route compound structure diagram
    ACYCJI64817745-45-8 In Stock
  4. Then
  5. ACTPSA726 route product structure diagram
    ACTPSA72667562-19-0 In Stock
Inquiry

Comments (0)